Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$65.57 USD
-0.35 (-0.53%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $65.55 -0.02 (-0.03%) 4:48 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.16 |
EPS Last Quarter | -1.38 |
Last EPS Surprise | -33.98% |
ABR | 1.44 |
Earnings ESP
|
-16.29% |
---|---|
Current Year | -4.50 |
Next Year | -3.15 |
EPS (TTM) | -5.45 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.14M | 0.99M | 15.39M | 165.07M |
# of Estimates | 7 | 8 | 8 | 9 |
High Estimate | 2.00M | 1.20M | 54.00M | 394.66M |
Low Estimate | 0.75M | 0.75M | 3.00M | 58.18M |
Year ago Sales | 4.61M | 0.87M | 7.53M | 15.39M |
Year over Year Growth Est. | -75.38% | 14.14% | 104.40% | 972.50% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.16 | -1.16 | -4.50 | -3.15 |
# of Estimates | 11 | 10 | 12 | 10 |
Most Recent Consensus | -1.27 | -1.27 | -4.00 | -3.74 |
High Estimate | -0.92 | -0.99 | -3.72 | -1.53 |
Low Estimate | -1.35 | -1.36 | -5.42 | -5.00 |
Year ago EPS | -1.38 | -1.34 | -5.45 | -4.50 |
Year over Year Growth Est. | 15.94% | 13.43% | 17.43% | 30.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 3 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 2 | 7 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.16 | -1.16 | -4.50 | -3.15 |
7 Days Ago | -1.16 | -1.16 | -4.50 | -3.15 |
30 Days Ago | -1.16 | -1.16 | -4.51 | -3.18 |
60 Days Ago | -1.07 | -1.05 | -4.46 | -3.34 |
90 Days Ago | -1.07 | -1.05 | -4.46 | -3.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.35 | -1.36 | -4.92 | -3.97 |
Zacks Consensus Estimate | -1.16 | -1.16 | -4.50 | -3.15 |
Earnings ESP | -16.29% | -17.44% | -9.44% | -26.19% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.38 | -1.35 | -1.34 | -1.38 | NA |
Estimate | -1.03 | -0.72 | -1.23 | -1.24 | NA |
Difference | -0.35 | -0.63 | -0.11 | -0.14 | -0.31 |
Surprise | -33.98% | -87.50% | -8.94% | -11.29% | -35.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more